3[4]Galkin EV, Grakov BS, Protopopov AV. First clinical experience of radio-endovascular functional thyroidectomy in the treatment of diffuse toxic goiter. Vestin Rentgenol Radiol (Russian), 1994, 3:29-35.
4[1]Galkin EV, Grakov BS, Protopov AV. First clinical experience of radioendo-vascular functional thyroidectomy in the treatment of diffuse toxic goiter. Vestin Rentgenol Radiol,1994,3: 29-35.
6[3]Xiao HP, Zhuang WQ, Wang S, et al. Arterial embolization: a noval approach to thyroid ablative therapy for Grave's disease.J Clin Endocrinol Metabol, 2002, 87: 3583-3589.
7[11]Alp MN, Ozgen A, Can I, et al. Colour Doppler imaging of orbital vasculature in Graves' disease with computed tomographic correlation. Br Ophthalmol 2000, 84: 1027-1030.
8[3]Galkin EV, Grakov BS, Protopopov AV. First clinical experience of radioendo-vascular functional thyroidectomy in the treatment of diffuse toxic goiter. Vestin Rentgenol Radiol, 1994,3:29-35.
9[3]Arslan H, Unal O, Algan E, et al. Power Doppler sonography in the diagnosis of Graves' disease. Eur J Ultrasound, 2000, 11:117-122.
10[4]Saleh A, Furst G, Feldlamp J, et al. Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color Doppler sonography. Ultrasound Med Biol, 2001, 27:1137-1141.
5Mori T, Sugawa H, Kosugi S, et al. Effectiveness of a Shot term Steroid Treatment on the Reduction in Goiter Size in Antithyroid Drug-treated Patients with Graves Disease[J] Endocr J,1997,44(4) :575-580.
6Bennedbaek F N, Karstup S, Hegedus L. Percutaneous Ethanol Injection Therapy in the Thyroid and Parathyroid Diseases[J]. Eur J Endoerinol,1997,136(3) :240-250.
7Marti U,Ruchti C,Kampf J,et al. Nuclear Localization of Epidermal Growth Factor and Epidermal Growth Factor Receptors in Human Thyroid Tissues[J]. Thyroid, 2001,11 : 137- 145.
